Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35061863)

  • 1. Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis.
    Zhou J; Guo H; Zhang Y; Liu H; Dou Q
    PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta-analysis.
    Li S; Wang X; Li Q; Li C
    Oncol Lett; 2023 Jan; 25(1):19. PubMed ID: 36478896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP2 is involved in the occurrence, development and prognosis of cancer.
    Li S; Qu J; Wang X; Zou Q; Li C
    Oncol Lett; 2023 Sep; 26(3):393. PubMed ID: 37600341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.
    Liu S; Chen S; Ma K; Shao Z
    Cancer Cell Int; 2018; 18():166. PubMed ID: 30386175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
    Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
    Front Immunol; 2018; 9():2077. PubMed ID: 30254644
    [No Abstract]   [Full Text] [Related]  

  • 6. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma.
    Jiang C; Hu F; Tai Y; Du J; Mao B; Yuan Z; Wang Y; Wei L
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):637-46. PubMed ID: 22228034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 and Survival in Solid Tumors: A Meta-Analysis.
    Wu P; Wu D; Li L; Chai Y; Huang J
    PLoS One; 2015; 10(6):e0131403. PubMed ID: 26114883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of SHP2 in gastric cancer.
    Dong S; Li FQ; Zhang Q; Lv KZ; Yang HL; Gao Y; Yu JR
    J Int Med Res; 2012; 40(6):2083-9. PubMed ID: 23321164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.
    Huang Y; Wang J; Cao F; Jiang H; Li A; Li J; Qiu L; Shen H; Chang W; Zhou C; Pan Y; Lu Y
    Sci Rep; 2017 Dec; 7(1):17597. PubMed ID: 29242509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
    Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
    Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
    Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
    Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
    Xu M; Xu S
    Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.
    Chen L; Xie Y; Li X; Gu L; Gao Y; Tang L; Chen J; Zhang X
    Onco Targets Ther; 2017; 10():2849-2863. PubMed ID: 28652767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhou X; Sun L; Jing D; Xu G; Zhang J; Lin L; Zhao J; Yao Z; Lin H
    Front Physiol; 2018; 9():452. PubMed ID: 29765332
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis.
    Liu Y; Tang W; Xie L; Wang J; Deng Y; Peng Q; Zhai L; Li S; Qin X
    Tumour Biol; 2014 Apr; 35(4):3145-54. PubMed ID: 24258111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
    Li J; Gao JZ; Du JL; Wei LX
    World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of PTP1B (PTPN1) in the prognosis of solid tumors: A meta-analysis.
    Zhou J; Guo H; Zhang Y; Liu H; Dou Q
    Medicine (Baltimore); 2022 Oct; 101(40):e30826. PubMed ID: 36221386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
    Front Immunol; 2020; 11():1242. PubMed ID: 32714321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.